Zymeworks BC Inc (NASDAQ:ZYME) shares, rose in value on Thursday, March 06, with the stock price down by -7.97% to the previous day’s close as strong demand from buyers drove the stock to $12.13.
Actively observing the price movement in the last trading, the stock closed the session at $13.18. Referring to stock’s 52-week performance, its high was $17.70, and the low was $7.97. On the whole, ZYME has fluctuated by -14.82% over the past month.
With the market capitalization of Zymeworks BC Inc currently standing at about $842.41 million, investors are eagerly awaiting this quarter’s results, scheduled for in April.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 98.38M, with a low estimate of 8.6M and a high estimate of 41M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 20.57M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ZYME’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ZYME currently trading nearly -12.54% and -14.42% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 34.85, while the 7-day volatility ratio is showing 5.57% which for the 30-day chart, stands at 5.29%. Furthermore, Zymeworks BC Inc (ZYME)’s beta value is 1.16, and its average true range (ATR) is 0.76.
A comparison of Zymeworks BC Inc (ZYME) with its peers suggests the former has fared considerably weaker in the market. ZYME showed an intraday change of -7.97% in last session, and over the past year, it shrunk by -3.04%%.
Data on historical trading for Zymeworks BC Inc (NASDAQ:ZYME) indicates that the trading volumes over the past 3 months, they’ve averaged 463.38K. According to company’s latest data on outstanding shares, there are 68.96 million shares outstanding.
Nearly 4.07% of Zymeworks BC Inc’s shares belong to company insiders and institutional investors own 96.25% of the company’s shares. The stock has fallen by -17.14% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ZYME stock heading into the next quarter.
